When an immune thrombocytopenia (ITP) relapse occurs, it’s always a huge disappointment and reminder that this is an illness that will never go away. Once my platelets become stable, I enter the ...

Patients with PCNSL experience faster cerebral atrophy after consolidation therapy and the rate of atrophy is similar between standard consolidation strategies. Patients with primary central nervous ...

Out of the 38 patients who received rituximab in combination with avatrombopag, 79% responded within 30 days of combination therapy. Real-world data support the potential of avatrombopag for treating ...

Which of the statements below about life expectancy in pulmonar y arterial hypertension (PAH) are correct? Select one of the options for each question, then submit your answers to see how well you ...

The majority of non-responders at Cycle 1 of rozanolixizumab treatment became responders at Cycle 2. Rozanolixizumab significantly improves myasthenia gravis (MG)-specific outcomes compared to placebo ...

The study reported the pooled prevalence estimates for coronary artery disease, congestive heart failure, cerebrovascular diseases, hypertension, and myocardial infarction among patients with MG.

Unlike MS, NMOSD does not respond to immunomodulatory therapy and requires permanent immunosuppression. A review of the current diagnostic and management strategies for neuromyelitis optica spectrum ...

Best Practice Advisory alerts clinicians to existing ABO/Rh test results when the Advanced Nursing Initiative for vaginal bleeding in pregnancy is used. A recent investigation suggests that electronic ...

Microscopic polyangiitis was the most common subtype of AAV among patients with Pneumocystis jirovecii pneumonia. A newly published study examines the characteristics of Pneumocystis jirovecii ...

This is only the second case report of using avacopan as an adjunctive treatment to rituximab in inducing steroid-free remission in GPA-associated ocular inflammation. A patient with scleritis and ...

The authors presented two cases in which the onset of pulmonary symptoms led to the diagnosis of CTD-ILD in patients with a history of NMOSD. The onset of pulmonary symptoms in patients with ...